drugset / Trial / NCT00054860

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

NCT00054860 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to test the safety of an HIV DNA vaccine (EP HIV-1090) and to test whether or not the vaccine can stimulate immune system responses in HIV uninfected people. This vaccine uses only parts of the virus's DNA and cannot cause HIV infection.

Timeline

Start
—
Primary completion
—
Completion
2005-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject EP HIV-1090 Vaccine — Intramuscular